Precision Lung Cancer 2018
An exclusive, annual biopharma conference providing insights into the research and development of cutting edge treatments for Lung Cancer and a networking forum for precision medicine leaders in this space.
Lung Cancer is the leading cause of cancer death worldwide. It is difficult to detect in its early stages, as well as understand and treat effectively.
Lung cancer R&D is experiencing rapid growth, representing an enormous opportunity for drug developers, with a 22% rise in new candidates in 2015.
The global market for Lung cancer therapeutics, currently valued at $5 billion is poised to reach $15.1 billion by 2023, expanding by a CAGR of 12%
Event Properties
| Event Date | 29 Oct 2018 10:00 AM |
| Event End Date | 30 Oct 2018 6:00 PM |
| Registration Start Date | 10 Apr 2018 |
| Capacity | 1000 |
| Available place | 1000 |
| Name of the Organizer: | NEO SYNTH |
| Person of Contact | Kerin Kar |
| Location | Boston |